Archana Radhakrishnan, MD, MHS

Archana Radhakrishnan, MD, MHS
Assistant Professor of Internal Medicine
Medical School
[email protected]
Available to mentor
Archana Radhakrishnan, MD, MHS
Archana Radhakrishnan, MD, MHS
Assistant Professor
  • About
  • Qualifications
  • Center Memberships
  • Recent Publications
  • Manage Your Profile

  • About

    Dr. Archana Radhakrishnan is an Assistant Professor in the Department of Medicine at the University of Michigan. She is a primary care physician (PCP) practicing at the Ann Arbor VA and cancer health services researcher. She received her MD from the University of Illinois at Chicago and completed residency in Internal Medicine at Case Western Reserve University. She additionally completed a General Internal Medicine clinical research fellowship at Johns Hopkins University, where she also received a Master in Health Science (MHS) from the Bloomberg School of Public Health.

    Dr. Radhakrishnan’s clinical and research interests align to ultimately improve the quality of care of patients with cancer. Specifically, she focuses on understanding and optimizing the role of PCPs in the care of patients throughout the cancer continuum. Her projects include examining the role of PCPs for patients with low-risk cancers. She is the PI on a NCI-funded K08 award to develop and test an intervention to engage PCPs to support men with low-risk prostate cancer on active surveillance. Currently, Dr. Radhakrishnan is developing and implementing team-based models involving PCPs to improve cancer survivorship care delivery.

    Qualifications

    • General Internal Medicine Clinical Research Fellowship
      Johns Hopkins University School of Medicine, Baltimore, United States
      2014 - 2017
    • MHS
      Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
      2014 - 2016
    • MD
      University of Illinois at Chicago College of Medicine, 1853 W. Polk (MC 785), Chicago, IL, 60612-7332, United States
      2005 - 2009

    Center Memberships

    • Center Member
      AI and Digital Health Innovation
    • Center Member
      Rogel Cancer Center
    • Center Member
      Institute for Healthcare Policy and Innovation

    Recent Publications

    See All Publications
    • Journal Article
      Patient-reported duplication and missed breast cancer survivorship care more than 5 years after initial treatment.
      Wallner LP, Furgal AKC, Veenstra CM, Kurian AW, Hamilton AS, Ward KC, Hawley ST, Katz SJ, Radhakrishnan A. J Cancer Surviv, 2026 May 11; DOI:10.1007/s11764-026-02038-w
      PMID: 42115496
    • Journal Article
      Patient-reported duplication and missed breast cancer survivorship care more than 5 years after initial treatment.
      Wallner LP, Furgal AKC, Veenstra CM, Kurian AW, Hamilton AS, Ward KC, Hawley ST, Katz SJ, Radhakrishnan A. J Cancer Surviv, 2026 May 11; DOI:10.1007/s11764-026-02038-w
      PMID: 42115496
    • Proceeding / Abstract / Poster
      Developing quality cancer survivorship care competencies for primary care: a modified Delphi study
      Eary R, Erickson M, Ganschow PS, Gilmore KR, Hong S, Kim J, Manst D, McClellan S, McDonough AL, Peairs KS, Radhakrishnan A, Roth M, Siegel S, Schapira L, Topalian A, Yurkiewicz I, Nekhlyudov L, Choi Y. 2026 May 19;
    • Proceeding / Abstract / Poster
      Developing quality cancer survivorship care competencies for primary care: a modified Delphi study
      Eary R, Erickson M, Ganschow PS, Gilmore KR, Hong S, Kim J, Manst D, McClellan S, McDonough AL, Peairs KS, Radhakrishnan A, Roth M, Siegel S, Schapira L, Topalian A, Yurkiewicz I, Nekhlyudov L, Choi Y. 2026 May 19;
    • Proceeding / Abstract / Poster
      Evaluating Care Management as a System-Level Intervention for Colorectal Cancer Screening
      Zaire P, Wallner LP, Radhakrishnan A. 2026 May 3;
    • Proceeding / Abstract / Poster
      Evaluating Care Management as a System-Level Intervention for Colorectal Cancer Screening
      Zaire P, Wallner LP, Radhakrishnan A. 2026 May 3;
    • Journal Article
      Predicting Long-Term Risk for Prostate Cancer Mortality Following a Prostate-Specific Antigen Screening Test: Prognostic Model Development and External Validation.
      Lewicki P, Jiang R, Radhakrishnan A, Bryant A, Schipper M, Morgan TM, Stensland K. Ann Intern Med, 2026 Mar; 179 (3): 321 - 329. DOI:10.7326/ANNALS-25-02036
      PMID: 41525694
    • Journal Article
      Predicting Long-Term Risk for Prostate Cancer Mortality Following a Prostate-Specific Antigen Screening Test: Prognostic Model Development and External Validation.
      Lewicki P, Jiang R, Radhakrishnan A, Bryant A, Schipper M, Morgan TM, Stensland K. Ann Intern Med, 2026 Mar; 179 (3): 321 - 329. DOI:10.7326/ANNALS-25-02036
      PMID: 41525694